John A Tainer Selected Research

John A Tainer Research Topics

Disease

56	Neoplasms (Cancer) 05/2024 - 07/2003
19	Genomic Instability 01/2023 - 11/2004
7	Infections 01/2024 - 07/2003
6	Breast Neoplasms (Breast Cancer) 05/2024 - 09/2003
5	Carcinogenesis 01/2021 - 07/2008
5	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2011 - 08/2007
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2009 - 11/2002
3	Bites and Stings (Sting) 04/2024 - 01/2021
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Nijmegen Breakage Syndrome 01/2018 - 08/2007
3	Werner Syndrome (Werner's Syndrome) 06/2011 - 05/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2009 - 09/2003
3	Dehydration (Water Stress) 03/2006 - 10/2003
2	Trichothiodystrophy Syndromes 01/2023 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2019 - 02/2009
2	Cockayne Syndrome (Syndrome, Cockayne) 01/2019 - 10/2005
2	Inflammation (Inflammations) 04/2016 - 11/2008
2	Virus Diseases (Viral Diseases) 06/2012 - 01/2011
2	Premature Aging 06/2011 - 05/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024
1	Human Influenza (Influenza) 01/2024
1	Hypoxia (Hypoxemia) 01/2022
1	Hyperthermia 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Autism Spectrum Disorder 01/2021
1	Autistic Disorder (Autism) 01/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

30	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 11/2004
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
10	Phosphotransferases (Kinase)IBA 04/2024 - 08/2007
9	EnzymesIBA 01/2021 - 04/2007
6	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2021 - 10/2009
5	UbiquitinIBA 04/2016 - 09/2007
5	Superoxide DismutaseIBA 04/2009 - 11/2002
4	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2011
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 12/2019
4	Ligases (Synthetase)IBA 11/2021 - 09/2007
4	Flap EndonucleasesIBA 01/2017 - 04/2010
3	Adenosine Triphosphatases (ATPase)IBA 10/2023 - 04/2011
3	Adenosine Triphosphate (ATP)IBA 01/2023 - 04/2011
3	A-Form DNA (A-DNA)IBA 03/2022 - 05/2014
3	B-Form DNA (B-DNA)IBA 01/2022 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2015
3	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021 - 12/2010
3	EndonucleasesIBA 01/2020 - 04/2010
3	Superoxide Dismutase-1IBA 10/2014 - 11/2002
3	Alkyl and Aryl TransferasesIBA 11/2010 - 08/2007
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
2	Peptides (Polypeptides)IBA 04/2024 - 03/2006
2	InterferonsIBA 04/2024 - 01/2021
2	CytokinesIBA 03/2024 - 01/2021
2	Novobiocin (Streptonivicin)FDA Link 10/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2009
2	Oxygen (Dioxygen)IBA 11/2021 - 10/2003
2	ChromatinIBA 11/2021 - 01/2020
2	poly ADP-ribose glycohydrolaseIBA 01/2021 - 12/2019
2	CollagenIBA 01/2021 - 01/2018
2	PhosphopeptidesIBA 01/2018 - 08/2007
2	Phosphates (Orthophosphate)IBA 01/2017 - 01/2017
2	CopperIBA 10/2014 - 11/2007
2	Cysteine (L-Cysteine)FDA Link 11/2010 - 06/2009
2	Exonucleases (3' 5' Exonuclease)IBA 08/2010 - 05/2006
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2009 - 08/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024
1	Mitochondrial DNA (mtDNA)IBA 04/2024
1	Toll-Like Receptor 9IBA 04/2024
1	nardilysinIBA 04/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	lariat debranching enzymeIBA 01/2023
1	Rad51 RecombinaseIBA 01/2023
1	CamptothecinIBA 03/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 03/2022
1	Replication Protein AIBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2021
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	DNA-Activated Protein KinaseIBA 01/2021
1	VaccinesIBA 01/2021
1	Floxuridine (FUdR)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	UracilIBA 01/2021
1	UDP glucose-collagen glucosyltransferase (procollagen glucosyltransferase)IBA 01/2021
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2021
1	HeterochromatinIBA 01/2021
1	high density lipoprotein binding proteinIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021

Therapy/Procedure

9	Therapeutics 05/2024 - 07/2006
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2004
2	Ligation 03/2022 - 08/2015
2	Immunotherapy 01/2022 - 01/2021
1	Traction 01/2022